Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01581125 · ClinicalTrials.gov registry record · NA
Sleep Duration Required to Restore Performance During Chronic Sleep Restriction
A NA study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 19
- Enrollment target
NCT01581125 is a NA study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 19 participants.
The verdict
NCT01581125, a NA study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
Study Summary
The purpose of this study is to test the hypothesis that sleep and performance depend on length of time awake, length of time asleep, the amount of sleep over several sleep episodes, and circadian phase.
Interventions
- BEHAVIORAL Sleep:wake 1
- BEHAVIORAL Sleep:wake 2
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2012-04 |
| Est. Completion | 2016-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01581125
The ClinicalTrials.gov registry entry for NCT01581125 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sleep:wake 1 is the first listed.
NCT01581125 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01581125 about?
NCT01581125 is a clinical study titled "Sleep Duration Required to Restore Performance During Chronic Sleep Restriction". The purpose of this study is to test the hypothesis that sleep and performance depend on length of time awake, length of time asleep, the amount of sleep over several sleep episodes, and circadian phase.
What is the current status of trial NCT01581125?
This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2012-04. Estimated completion is 2016-06.
What interventions are being tested in trial NCT01581125?
The interventions under investigation include: Sleep:wake 1 (BEHAVIORAL), Sleep:wake 2 (BEHAVIORAL).
Who is sponsoring clinical trial NCT01581125?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.